The innovation of the new treatments has outpaced the rate at which NICE (The National Institute for Health and Care Excellence) appraises the treatments via its existing method of appraisal. NICE recently announcing taking a “proportionate approach” to technology appraisals is a landscape change ensuring faster guidance and efficiency gains.
This blog covers the latest developments in the Antimicrobial Resistance (AMR) space and how the UK’s recently approved ‘Netflix-style’ subscription-based payment model can work as an example to the world to reverse the decline in the antibiotics category.
Updated on 30th July 2022 The guidelines for Innovative Medicines Fund (IMF) have been issued by NHS on June 6, 2022. The design of the IMF has been largely drawn on the lines of Cancer Drug Funds (CDF). Along with the guidelines, the responses to engagement on...
Remember the dilemma of Alan Turing from the movie The Imitation Game where to optimize for a war winning strategy he happened to decide on the fate of American soldiers?Sometimes people have to play God as we have to accept the harsh truth of life that...
